These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Gilbert DB, Millar J, Cooper SJ. Brain Res; 1995 May 29; 681(1-2):1-7. PubMed ID: 7552265 [Abstract] [Full Text] [Related]
26. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. Starr MS, Starr BS. Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603 [Abstract] [Full Text] [Related]
30. The effect of repeated treatment with pramipexole on the central dopamine D3 system. Maj J, Rogói Z, Margas W, Kata M, Dziedzicka-Wasylewska M. J Neural Transm (Vienna); 2000 Apr 24; 107(12):1369-79. PubMed ID: 11458990 [Abstract] [Full Text] [Related]
31. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Barik S, de Beaurepaire R. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 24; 29(5):718-26. PubMed ID: 15913875 [Abstract] [Full Text] [Related]